ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,399.22
-0.51%
US Tech 100
18,362.80
-0.93%
Dow Jones
39,935.07
0.20%
Brent Oil
81.605
0.09%
Bitcoin
66,936.27
1.74%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Mithra Pharmaceuticals SA (MITRA) Quote

Mithra Pharmaceuticals SA

Mithra Pharmaceuticals SA (MITRA)

EU
0.216
0.00
(0.00%)
Closed July 26 11:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.216
Bid
0.13
Ask
0.23
Volume
0.00
0.00 Day's Range 0.00
0.201 52 Week Range 3.87
Market Cap
12.655M
Previous Close
0.216
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
0.00
Shares Outstanding
58,587,000
Dividend Yield
-
PE Ratio
-0.07
Earnings Per Share (EPS)
-2.96
Revenue
40.16M
Net Profit
-173.5M

About Mithra Pharmaceuticals SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.mithra.com
Headquarters
Liege, Liege, Bel
Founded
1970
Mithra Pharmaceuticals SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker MITRA. The last closing price for Mithra Pharmaceuticals was 0.22 €. Over the last year, Mithra Pharmaceuticals shares have traded in a share price range of 0.201 € to 3.87 €.

Mithra Pharmaceuticals currently has 58,587,000 shares outstanding. The market capitalization of Mithra Pharmaceuticals is 12.65 € million. Mithra Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.07.

MITRA Latest News

More News

Mithra postpones its annual general meeting

Liege, Belgium, 28 May 2024 – 15:00 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, today announces that in the context of the monetization process and the...

May 28 2024
GlobeNewswire Inc.

Mithra enters into exclusive negotiations with Gedeon Richter and secures continued funding in the context of its monetization process

Liege, Belgium, 3 May 2024 – 17:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, today announces that, after diligent evaluation of several binding offers...

May 03 2024
GlobeNewswire Inc.

Mithra updates on offers received in the context of its monetization process and on its Annual Report 2023

Mithra has received binding offers for selected assets, including Estetra SRL, as part of its monetization process. As it stands, the aggregate amount of these offers is insufficient to ensure...

April 29 2024
GlobeNewswire Inc.

Mithra secures court protection measures to advance monetization process

Court Grants "Transfer under Judicial Supervision" for CDMO facility, safeguarding Mithra's activities and expediting the M&A process for its Contract Development and Manufacturing...

April 22 2024
GlobeNewswire Inc.

Mithra reports full year 2023 financial results

Mithra reports full year 2023 financial results Mithra reports full year 2023 financial results Revenues were EUR 40.2 million, down from the 2022 result of EUR 67.0 million which was...

March 08 2024
GlobeNewswire Inc.

Mithra announces changes to its executive management

Mithra announces changes to its executive management Mithra announces changes to its executive management Liege, Belgium, 05 March 2024 – 07:00 CET – Mithra (Euronext Brussels: MITRA), a...

March 05 2024
GlobeNewswire Inc.

Mithra initiates monetization process, receives bridge loan from existing lenders

Mithra initiates monetization process, receives bridge loan from existing lenders    Mithra initiates monetization process, receives bridge loan from existing lenders Mithra appoints...

March 05 2024
GlobeNewswire Inc.

DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase

DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase           DONESTA® safety study for menopause completes treatment phase...

February 29 2024
GlobeNewswire Inc.

Mithra sells shares in Mayne Pharma

Mithra sells shares in Mayne Pharma           Mithra sells shares in Mayne Pharma Mithra sold all 4,221,815 shares it held in Mayne Pharma for EUR ~12.8 millionAs the Mayne Pharma shares...

February 15 2024
GlobeNewswire Inc.

Mithra updates on cash position

Mithra updates on cash position           Mithra updates on cash position Mithra's current cash of EUR 6.5 million is expected to cover its current cash runway through early MarchMithra is...

February 06 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
26-0.914-80.88495575221.131.1480.2013808180.41238228DE
52-1.824-89.41176470592.043.870.2012965991.19900989DE
156-20.284-98.946341463420.522.10.2011776224.01001513DE
260-27.804-99.229122055728.0232.960.2011313447.6019315DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
POAIPredictive Oncology Inc
$ 1.8696
(74.73%)
149.56M
SLRXSalarius Pharmaceuticals Inc
$ 3.2996
(54.19%)
31.1M
PBMPsyence Biomedical Ltd
$ 0.5865
(49.85%)
77.02M
NVNINVNI Group Ltd
$ 1.75
(44.63%)
4.12M
CMAXCareMax Inc
$ 5.60
(44.33%)
23.45M
TWOU2U Inc
$ 1.51
(-63.35%)
5.1M
XPONExpion360 Inc
$ 0.56
(-46.15%)
1.29M
KDLYKindly MD Inc
$ 1.97
(-38.82%)
821.97k
MXLMaxLinear Inc
$ 14.02
(-37.10%)
7.43M
CTNTCheetah Net Supply Chain Service Inc
$ 0.3047
(-36.78%)
12.79M
NVDANVIDIA Corporation
$ 112.28
(-1.72%)
447.63M
SQQQProShares UltraPro Short QQQ
$ 9.37
(3.42%)
244.13M
SLNASelina Hospitality PLC
$ 0.03755
(-17.83%)
177.23M
POAIPredictive Oncology Inc
$ 1.8696
(74.73%)
149.56M
TSLATesla Inc
$ 220.25
(1.97%)
96.7M

Discussion

View Full Feed
k9uwa k9uwa 6 minutes ago
I seriously think this $7.10 price will not hold in the morning. Soon after the open we will drop a bit. Although yes I would love to see us continue to RISE. Probably the $7.10 PPS in afterhours was some One or perhaps more than one SHORT being scared out of bagging their "Profit"

AVXL
CaptBeer CaptBeer 6 minutes ago
Our Friend, Dr John Nelson once again brilliantly showing the consistency of REDUCE-IT data and how safe VASCEPA/VAZKEPA is in the Real World. All the negative hype about bleeding and Afib with IPE is laid to rest.
AMRN
Welcome2Pinkyland Welcome2Pinkyland 9 minutes ago
Ouchie. Such high level insults.
janice shell janice shell 12 minutes ago
Amit invited me over -said he was eager to hear my opinions and feedback on the latest developments on the site, the new tools that have been introduced, and the message board itself.

Yes dear. Special for you!!

No wonder you still seem not to have noticed the OTC is de
janice shell janice shell 14 minutes ago
I thought you were going to tell me a secret way to save $$$

Just as easy!! Eat nothing but peanut butter!! Tasty, and packed with all kinds of wholesome stuff!!

You'll be just fine!!
Slaytanic420 Slaytanic420 15 minutes ago
Check out pwdy
OPTI
vinmantoo vinmantoo 16 minutes ago
Where is the capital for the $300 million for Phase 3 clinical trials?

What?? If you have done even the barest minimum of research on VKTX you would know they have over $900 million in cash on hand.
VKTX
vinmantoo vinmantoo 18 minutes ago
The FDA hasn't approved Phase 3 clinical trials. Viking didn't provide the FDA guidance they received.

What a freaking genius! VKTX said after discussion with the FDA they are moving forward into phase 3 and will meet with FDA later this year to how to structure the phase 3 trials. Ob
VKTX
IBB-99 IBB-99 19 minutes ago
Potentially explosive stock, according to Coin Codex:


https://investorshub.advfn.com/uimage/uploads/2024/7/26/oeeztCoin_Codex.JPG



https://coincodex.com/stock/LWLG/price-prediction/
LWLG
XMaster2023 XMaster2023 21 minutes ago
Ashkan is a well respected Neurosurgeon. You on the other hand an unknown fudster,
NWBO
fuagf fuagf 22 minutes ago
OMOLIVES, One thing we know, no Trump administration would close a tax loophole.

https://www.politifact.com/truth-o-meter/promises/trumpometer/promise/1429/eliminate-carried-interest-loophole/
surfer44 surfer44 22 minutes ago
Thanks for the invite!
ignatiusrielly35 ignatiusrielly35 22 minutes ago
It’s humorous that you showed up out of the blue. Where have you been? Just a coincidence, huh?

Cue the: I’m not really interested but I suddenly felt that I had to save everyone shtick. Are you still long? 🕺
AVXL
knrorrel knrorrel 23 minutes ago
great news https://www.otcmarkets.com/stock/NWPN/news/The-Now-Corporation-OTCNWPN-Enters-The-Artificial-Intelligence-War-Armed-With-A-Strategic-Acquisition?id=447987
NWPN
Steady_T Steady_T 23 minutes ago
If only ...
knrorrel knrorrel 24 minutes ago
great tweet https://x.com/thenowcorp/status/1816559039914082560?t=6Qssn1QhHFPVbnhDZbwBhQ&s=19
NWPN
fuagf fuagf 27 minutes ago
hap0206, All she said there is true. And you have been given links to prove it all before.
janice shell janice shell 27 minutes ago
Here ya go, Hap. Listen to him say it:

https://www.youtube.com/watch?v=aX0iAmz9iLM

And tell me about all the dictators of the past who assumed dictatorial powers and then gave them up after a day, or a week, or a year. And have you been following all the "Red Caesar" th
Wise Man Wise Man 27 minutes ago
The Table 8 (Payout ratio) of the Capital Rule has been used for the assertion that the dividend rate on the cumulative SPS has yet to be assessed (commented https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174799680 here ), despite that the SPS corresponding to the draws from the US
FNMA
georgejjl georgejjl 28 minutes ago
Reducing brain shrinkage (atrophy) definitely without a doubt improves Alzheimer’s disease.

https://www.nia.nih.gov/sites/default/files/inline-images/brain_slices_alzheimers_0.jpg

GOD bless,
AVXL
dinogreeves dinogreeves 29 minutes ago
Any complains about this board should be directed to Amit, the CEO of IHUB. Once Delfin announces the merger, I believe it will be safe to talk about politics.

https://investorshub.advfn.com/VIP-Investors-Forum-43084
TGLO
BlueChip$ BlueChip$ 30 minutes ago
Why no mention of the name of the audit firm?... Questionable PR imo
CBMJ
Kam8 Kam8 31 minutes ago
Amazing 👏.
NWBO
Dust2332 Dust2332 31 minutes ago
Nobody cares about your charts it's not even good as tp
HIRU

Your Recent History

EU
MITRA
Mithra Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved